Imperial College London


Faculty of MedicineDepartment of Infectious Disease

Senior Healthcare Research Scientist



+44 (0)20 3313 2732richard.wilson Website




7.S7aCommonwealth BuildingHammersmith Campus





Richard is a clinical pharmacist working in the DHSC Centre for Antimicrobial Optimisation and NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at Imperial College London. His research interests are around ß-lactam PK-PD relationships and individualising antimicrobial therapy with novel technologies.

He is also an antifungal stewardship pharmacist at Imperial College Healthcare NHS Trust.



Rawson TM, Wilson RC, O'Hare D, et al., 2021, Optimizing antimicrobial use: challenges, advances and opportunities, Nature Reviews Microbiology, ISSN:1740-1526

Rawson TM, Hernandez B, Moore L, et al., 2021, A real-world evaluation of a case-based reasoning algorithm to support antimicrobial prescribing decisions in acute care, Clinical Infectious Diseases, Vol:72, ISSN:1058-4838, Pages:2103-2111

Arkell P, Mahboobani S, Wilson R, et al., 2021, Bronchoalveolar lavage fluid IMMY Sona Aspergillus lateral-flow assay for the diagnosis of invasive pulmonary aspergillosis: a prospective, real life evaluation, Medical Mycology, Vol:59, ISSN:1369-3786, Pages:404-408

Rawson TM, Hernandez B, Wilson R, et al., 2021, Supervised machine learning to support the diagnosis of bacterial infection in the context of COVID-19, Jac-antimicrobial Resistance, Vol:3, ISSN:2632-1823, Pages:1-4

Rawson TM, Wilson R, Holmes A, 2020, Understanding the role of bacterial and fungal infection in COVID-19, Clinical Microbiology and Infection, ISSN:1198-743X

More Publications